Business
AstraZeneca moves to start making a profit from its vaccine – Sydney Morning Herald
After looking on as Pfizer and Moderna have made billions of dollars in sales, AstraZeneca is shifting to a for-profit model.
The vaccine isnt yet authorised in the US, after the company missed the window for an emergency authorisation due to the complicated nature of its trial results. Astra is planning to submit the shot for approval to regulators in the first half of next year,…
Continue Reading
-
Noosa News15 hours agoNRL legend Trevor Gillmeister charged with assaulting police officer at Brisbane pub
-
General23 hours agoKim Kardashian not deterred by bar failure
-
Business18 hours agoMacquarie tips more than 20% upside for this ASX mining stock
-
Noosa News16 hours agoSchools ban e-bikes | Noosa Today